In a ground-breaking medical success, HCG Manavata Cancer Centre (HCGMCC) marked a significant milestone by successfully performing three complex stem cell transplants simultaneously. For the first time, three patients, a female aged 52 years and two males aged 37 and 33 years were admitted on October 28, 2024, and discharged together on December 1, 2024, all with smiles on their faces. The first female patient, diagnosed with multiple myeloma and chronic kidney disease, underwent a critical autologous stem cell transplant. The Second patient diagnosed with relapsed/refractory Hodgkin Lymphoma underwent successful autologous Stem Cell Transplant and the third patient, battling high-risk leukaemia, underwent a complex half-match allogeneic transplant.

Dr Priyatesh Dwivedi

The transplant for all three patients was successfully conducted by Dr Priyatesh Dwivedi, Hemato-oncology and BMT Specialist, along with his dedicated team. This accomplishment adds another milestone for HCG Manavata Cancer Centre, which now boasts a remarkable record of 26 successful transplants within just 24 months.

“An autologous stem cell transplant involves harvesting a patient’s own stem cells and re-infusing them after intensive chemotherapy or radiation. For our first patient, this procedure was particularly complex due to significantly elevated creatinine levels, increasing the risk of acute kidney injury. However, with meticulous planning and the application of Modified Protocols, we successfully overcame these challenges, achieving a positive outcome,” says Dr Priyatesh Dwivedi.

The second transplant was complicated because of poor stem cell yield after the first stem cell harvest. Typically, at least two million stem cells are required for stem cell transplant but, only 0.86 million stem cells could be harvested. After the first stem cell collection, predicting poor stem cell yield during the second stem cell harvest, Dr Priyatesh Dwivedi used a novel modified chemo mobilisation procedure instead of going for a second stem cell harvest. With this chemo mobilisation procedure, adequate stem cell were harvested and successful transplant was done.

“Our second patient, a relapsed or refractory lymphoma case with chronic hepatitis B, encountered significant challenges during the initial stem cell mobilization, which failed to yield sufficient Stem cells for transplantation. Through a specialized chemo-mobilization procedure, we successfully collected the adequate stem cells. Similarly, the third patient presented a high-risk leukaemia case with heightened dangers of graft rejection and graft-versus-host disease and underwent successful half match transplant. Despite these complexities, we successfully performed these transplants with the team’s expertise and determination,” adds Dr Dwivedi.

“The achievement reflects our commitment to providing advanced medical care with precision and compassion. Successfully completing three transplants, including a critical half-match procedure, is a testament to the skill and dedication of our multidisciplinary team,” concludes Dr Raj Nagarkar, MD & Chief of Surgical Oncology & Robotic Services, HCG Manavata Cancer Centre (HCGMCC).

About HCG Manavata Cancer Centre (HCGMCC): –

Established in 2007 by Dr Raj Nagarkar, HCGMCC – Nashik is Central India’s first NABH-accredited facility. With over 50 consultant oncologists, 900 staff members and a 275-bed capacity, HCGMCC is a leading institution, offering holistic cancer treatment. Specializing in surgical, radiation and medical oncology, the centre has conducted 65,000 surgeries, including 1,100 plus robotic-assisted procedures. Patient-centric and multidisciplinary, HCGMCC recommends treatments to individual needs. Beyond clinical excellence, the centre’s financial aid programs underscore its commitment to accessibility and community well-being, redefining cancer care in the pursuit of a cancer-free future.

On the auspicious occasion of Deepawali, renowned table tennis player Nitesh Kumavat launched his new sports shop ‘Winner Sports & Fitness’ at Prathamesh Leela Society in new MHB Colony, Borivali (West).

TT Players Mr. Gomes, Ulhas, Santosh, Siddhi & Pranjal at the launch of new Sports shop in Borivali West by Nitesh Kumavat ( Centre) .

Nitesh who is a self made person, already owns one sports shop at Kasturba Cross Road in Borivali East, but he felt that the fastest growing Western part of Borivali had more potential for flourishing his business. His father is into tiles business; but, Nitesh preferred his own field, as he is really passionate about sports activity. Out of his busy schedule, he does find time daily for his TT practice. Incidentally, during the MCF Premier TT League few months ago, Nitesh had played for Team magzmumbai.

Nitesh Kumavat ( 2nd from L)being greeted by Mahesh Shetye( Ext. L) TT player and former Chief Manager , Bank of Baroda, TT player Sanjeev Dandavate & rising TT Star Sagar Kasture.

Many of his friends from table tennis fraternity, were personally present during the opening ceremony of his new outlet. Speaking about expanding his business and need for opening this new shop, Nitesh said, “There is a lot of demand for sports goods in this area and therefore after making a survey, I decided to open this new shop here. ‘Winner Sports & Fitness’ are specialised in Cricket kit bags, badminton, table tennis ,Football, Hockey ,Tennis, Pickleball equipments; besides fitness provisions.

Nashik’s leading cancerspeciality hospital – HCG Manavata Cancer Centre (HCGMCC) is hosting a special event titled ‘Pink Mela’ as part of its Breast Cancer Awareness Month initiatives at the hospital on 26^th October 2024. Aimed at raising awareness about the increasing cases of breast cancer, the event offers free consultations along with live demonstration for women above the age of 20 years. A dedicated team of doctors will be available to review medical histories, including any breast cancer or other relevant conditions, and conduct physical examinations, if necessary. In addition, the hospital is offering mammography tests at a reduced fee of Rs.550/- as against the regular fee of Rs.7150/- for the month.

“Breast cancer accounts for nearly 30 percent of all cancers among women in India, making it the most common cancer affecting women in the country. The risk of breast cancer increases with age, particularly for women in their 50s and 60s. Unfortunately, most cases are detected at a later stage due to a lack of awareness and early screening programs. With Pink Mela, we aim to raise awareness about breast cancer and educate women on the preventive measures they can take to reduce the risk. Pink Mela attendees are three times more likely to schedule their regular check-ups. I encourage as many women as possible to attend,” says Dr Raj Nagarkar, MD & Chief of Surgical Oncology & Robotic Services, HCGMCC.

Breast cancer is a disease that begins in the cells of the breast, where they grow and multiply uncontrollably, forming a mass or lump. While breast cancer primarily affects women, men can also develop it. Recently, Dr Raj Nagarkar achieved a milestone in breast cancer surgery by performing the world’s first robotic-assisted nipple-sparing mastectomy (RNSM).

“Several factors, including late pregnancies, family history, hormonal changes and lifestyle habits like smoking and high stress, can increase the risk of developing breast cancer. With its growing prevalence, it’s essential to promote awareness and regular screenings to combat this health crisis. Early detection increases the chances of survival by 80 per cent. The Pink Mela aims to empower women through preventive care and routine check-ups, particularly for those at higher risk,” concludes Dr Nagarkar.

India’s leading oncologist – Dr Raj Nagarkar contributed to a historic milestone in Jordan’s medical advancement by playing a pivotal role in the country’s first-ever successful robotic radical hysterectomies. The ground-breaking surgeries were performed at the King Hussein Cancer Center (KHCC) in the capital, Amman. The complex procedures, led by KHCC’s Dr Qais Shatnawi, were performed on two women patients aged 40 and 42 years, who were diagnosed with endometrial cancer. Dr Nagarkar from HCG Manavata Cancer Centre (HCGMCC), Nashik assisted Dr Shatnawi in this landmark surgery, marking a first in Jordan’s history. As one of India’s foremost robotic-assisted cancer surgeons, Dr Raj Nagarkar was invited to KHCC to lend support and expertize for ensuring the surgery’s successful execution.

Endometrial cancer is a type of cancer that develops in the lining of the uterus, called the endometrium. It arises from abnormal cell growth, which can potentially spread to other parts of the body.

“Assisting in Jordan’s first robotic radical hysterectomies at KHCC was an incredibly inspiring experience. The success of these surgeries is expected to open new avenues for the adoption of advanced robotic techniques in Jordan, particularly in the field of oncology. Also, the achievement highlights the power of collaboration and innovation in advancing healthcare. I am grateful to Dr Mahmoud Al Masri for his visionary leadership and Dr Qais Shatnawi for sharing his insights and skills during the surgeries,” says Dr Raj Nagarkar, MD & Chief of Surgical Oncology & Robotic Services, HCG Manavata Cancer Centre (HCGMCC).

KHCC, renowned for its commitment to excellence in cancer care, now joins a select group of institutions worldwide capable of performing such advanced robotic surgeries. The entire KHCC team played a crucial role in this success, demonstrating outstanding dedication and skill.

“Dr Raj Nagarkar is a pioneer in robotic surgery, and we are grateful for his invaluable contribution in performing Jordan’s first robotic radical hysterectomies. This landmark event not only enhances the collaboration between the Indian and Jordanian medical communities but also sets a new benchmark for cancer care in the region. As Jordan continues to invest in advanced medical technologies, the future looks promising for patients seeking cutting-edge treatment options,” adds Dr Mahmoud Al Masri, Chairman, Department of Surgery, KHCC.

A radical hysterectomy is a surgical procedure that involves the removal of the uterus, cervix, both ovaries, both fallopian tubes and surrounding tissue to treat endometrial cancer. This procedure is also used to address other gynaecological cancers, such as cervical and ovarian cancer. The surgeries performed at KHCC represent a major leap forward in the field of minimally invasive cancer treatment, offering enhanced precision, reduced recovery times and better outcomes for patients.

“This is just the beginning. The successful execution of the surgeries is a testament to the potential of robotics in revolutionizing cancer treatment globally. I look forward to further collaborations that push the boundaries of what we can achieve in medicine,” concludes Dr Nagarkar.

In a ground-breaking medical achievement,HCG Manavata Cancer Centre (HCGMCC) successfully performed North Maharashtra’s first T-Cell Replete Haploidentical (Half-Match) Stem Cell Transplant. The complex procedure, led by Dr Priyatesh Dwivedi, was conducted on 9-year-old girl from Tanzania, who had been battling sickle cell anaemia since she was just six months old. Despite visiting several hospitals, the girl’s family was repeatedly turned away due to the high risks associated with Haploidentical (Half-Match) Stem Cell Transplants, particularly the significant danger of graft rejection and primary graft failure. However, their search for hope ended at HCGMCC, where Dr Priyatesh Dwivedi, backed by an experienced Bone Marrow Transplant (BMT) team, successfully carried out the procedure without complications.

A haploidentical or half-match stem cell transplant involves using stem cells from a donor who is a partial genetic match to the patient, usually a first-degree relative such as a parent, sibling or child. For the 9 year-old girl, the donor was her own brother.

“Performing North Maharashtra’s first successful half-match stem cell transplant not only brings hope to families battling serious genetic disorders like sickle cell anaemia but also solidifies HCGMCC’s position as a leader in innovative and high-risk medical procedures. The innovative transplant protocol designed by Dr Dwivedi, combined with the skilled efforts of our staff, ensured a smooth procedure and swift recovery for the young girl,” says Dr Raj Nagarkar, MD & Chief of Surgical Oncology & Robotic Services, HCG Manavata Cancer Centre (HCGMCC).

Sickle cell anaemia is a genetic disorder where red blood cells become rigid and sickle-shaped, leading to blocked blood flow, pain and potential organ damage. It occurs when a person inherits two abnormal haemoglobin S genes, one from each parent.

Dr. Raj Nagarkar

About HCG Manavata Cancer Centre (HCGMCC): –

Established in 2007 by Dr Raj Nagarkar, HCGMCC – Nashik is Central India’s first NABH-accredited facility. With over 50 consultant oncologists, 900 staff members and a 275-bed capacity, HCGMCC is a leading institution, offering holistic cancer treatment. Specializing in surgical, radiation and medical oncology, the centre has conducted 65,000 surgeries, including 1,100 plus robotic-assisted procedures. Patient-centric and multidisciplinary, HCGMCC recommends treatments to individual needs. Beyond clinical excellence, the centre’s financial aid programs underscore its commitment to accessibility and community well-being, redefining cancer care in the pursuit of a cancer-free future.